Trials / Withdrawn
WithdrawnNCT02574962
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mamatha Pasnoor, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to assess the safety and efficacy of Acthar® Gel in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | H.P. Acthar® Gel |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2015-10-14
- Last updated
- 2016-07-18
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02574962. Inclusion in this directory is not an endorsement.